GlassScriptPhysician profile
Eric J Miknich
NPI 1124082995
$13,037.63
in general payments reported to CMS, 2019-2025
42 companies · $1,290 in 2025
The $1,290 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,104 · 2020: $1,460 · 2021: $2,182 · 2022: $1,973 · 2023: $2,052 · 2024: $1,977 · 2025: $1,290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,318.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,629.81 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $1,568.47 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,082.84 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $1,069.67 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $1,016.81 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $955.18 | 2019-2024 | Veozah, Myrbetriq |
| Pfizer INC. | $528.70 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $468.36 | 2019-2025 | |
| Amgen INC. | $463.28 | 2020-2025 | Evenity, Prolia, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $361.79 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $340.29 | 2019-2022 | |
| Allergan, INC. | $250.21 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $243.82 | 2019-2022 | |
| Exact Sciences Corporation | $240.01 | 2023-2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $230.03 | 2019-2025 | Eliquis, Camzyos |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Miknich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.